Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about IQVIA Holdings Inc.
IQVIA Holdings Inc. News
IQVIA Holdings Inc. Quantitative Score
About IQVIA Holdings Inc.
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.
IQVIA Holdings Inc. Earnings & Revenue
IQVIA Holdings Inc. Financials
Table Compare
Compare IQV metrics with: | |||
|---|---|---|---|
Earnings & Growth | IQV | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | IQV | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | IQV | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | IQV | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
IQVIA Holdings Inc. Income
IQVIA Holdings Inc. Balance Sheet
IQVIA Holdings Inc. Cash Flow
IQVIA Holdings Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Buy |
| Return on Equity | Buy |
| Return on Assets | Buy |
| Debt/Equity Ratio | Strong Sell |
| Price/Earnings Ratio | Strong Sell |
| Price/Book Ratio | Strong Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
IQVIA Holdings Inc. Valuation
Project future cash flows and get the intrinsic value per share.
Historical Market Cap
Shares Outstanding
IQVIA Holdings Inc. Executives
| Name | Role |
|---|---|
| Mr. Ari Bousbib | Chief Executive Officer & Chairman |
| Mr. Ronald E. Bruehlman | Executive Vice President & Chief Financial Officer |
| Mr. Eric M. Sherbet | Executive Vice President, General Counsel & Secretary |
| Mr. W. Richard Staub III | President of Research & Development Solutions |
| Dr. Cynthia L. Verst | President of Design & Delivery Innovation |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Mr. Ari Bousbib | Chief Executive Officer & Chairman | Male | 1961 | 7.15M |
| Mr. Ronald E. Bruehlman | Executive Vice President & Chief Financial Officer | Male | 1961 | 2.14M |
| Mr. Eric M. Sherbet | Executive Vice President, General Counsel & Secretary | Male | 1964 | 1.37M |
| Mr. W. Richard Staub III | President of Research & Development Solutions | Male | 1963 | 886.44K |
| Dr. Cynthia L. Verst | President of Design & Delivery Innovation | -- |
IQVIA Holdings Inc. Insider Trades
| Date | 27 Aug |
| Name | Sherbet Eric |
| Role | See Remarks |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 1300 |
| Date | 28 Jul |
| Name | Patel Bhavik |
| Role | See Remarks |
| Transaction | Disposed |
| Type | F-InKind |
| Shares | 83 |
| Date | 28 Jul |
| Name | Cherofsky Keriann |
| Role | See Remarks |
| Transaction | Disposed |
| Type | F-InKind |
| Shares | 35 |
| Date | 18 Jul |
| Name | Wims Morris Leslie |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 123 |
| Date | 18 Jul |
| Name | GOGGINS COLLEEN A |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 156 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 27 Aug | Sherbet Eric | See Remarks | Disposed | S-Sale | 1300 |
| 28 Jul | Patel Bhavik | See Remarks | Disposed | F-InKind | 83 |
| 28 Jul | Cherofsky Keriann | See Remarks | Disposed | F-InKind | 35 |
| 18 Jul | Wims Morris Leslie | Director | Acquired | A-Award | 123 |
| 18 Jul | GOGGINS COLLEEN A | Director | Acquired | A-Award | 156 |